dinutuximab beta

Spain

Drugs containing this active substance

  • QARZIBA 4.5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION

    It is used to treat neuroblastoma in patients 12 months of age or older, both in cases with a high risk of recurrence after other treatments (such as a stem cell transplant) and in cases where the cancer has returned or could not be completely treated.

    Form: solution for infusion, concentrate

    Active substance Dosage
    dinutuximab beta 4,5 mg

    ATC: L01F L01FX L01FX06

    Manufacturer: Recordati Netherlands B.V.